QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Pregnancy Prevention Programmes in the EU

Test your understanding of the concepts covered by GVP Module XVI: Pregnancy Prevention Programmes in the EU — Risk Minimisation and Member State Implementation.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which statement best reflects the article’s treatment of digitalisation in PPPs?

Electronic systems are automatically more effective than paper systems Paper systems cannot provide reliable point-of-care controls Effectiveness depends on whether the critical control operates, not simply on whether digital or paper technology is used Digitalisation eliminates the need for effectiveness evaluation

Question 2 of 10 Which statement best distinguishes EU-level requirements from national implementation?

National workflows can replace an EU-level requirement whenever they are more convenient All national operational details are automatically EU legal requirements The safety objective may be common while national systems determine the practical prescribing, testing, documentation and dispensing workflow EU-level requirements apply only where a country uses electronic prescribing

Question 3 of 10 Which regulatory development is correctly associated with the current framework described in the article?

GVP Module XVI Addendum I became legally effective on 29 August 2025 and addresses embryo-fetal-risk risk minimisation GVP Module XVI Addendum I became legally effective in 2015 and addresses only dispensing technology Addendum II replaced all product-specific risk-minimisation measures in 2024 Revision 3 of Module XVI became legally effective after Addendum I in 2026

Question 4 of 10 A study finds repeated pregnancies during treatment despite high rates of completed acknowledgement forms. What is the most appropriate interpretation?

The forms prove that the PPP is effective and no further review is needed The findings may indicate weaknesses in behaviour, counselling, testing, prescribing or dispensing and should be investigated as possible system signals The pregnancies are unrelated to risk minimisation because they were reported after treatment initiation The only appropriate response is to distribute more forms

Question 5 of 10 Why does the presence of an embryo-fetal or teratogenic risk not automatically require a full PPP?

Because embryo-fetal risks are addressed only through routine pharmacovigilance Because a PPP is selected proportionately, taking account of the risk, indication, population, duration and existing controls Because PPPs are permitted only for centrally authorised medicines Because pregnancy testing can never be used as an additional risk-minimisation measure

Question 6 of 10 A product is generally contraindicated during pregnancy but has an exception where no suitable alternative exists. What should the PPP do?

Convert the general precaution into an absolute prohibition in all circumstances Remove all pregnancy-prevention controls because an exception exists Make the eligibility condition and the clinical exception explicit so that the decision pathway is preserved Allow treatment whenever the patient signs an acknowledgement form

Question 7 of 10 A vendor distributes patient materials and operates a data-capture service for a PPP. Which statement is correct?

The vendor assumes the MAH’s responsibility for the risk-minimisation system The MAH remains responsible and should oversee critical-control performance, deviations, data quality and corrective actions Vendor activities do not need quality oversight if a contract exists Only the vendor’s financial performance needs to be monitored

Question 8 of 10 What makes pregnancy testing a meaningful risk-minimisation control?

The test is performed at any time before treatment, regardless of the treatment decision The test is technically valid, even if its result is not reviewed Its timing, interpretation, documentation and resulting action are linked to a prescribing or dispensing decision The patient receives a copy of the test without any further process

Question 9 of 10 What is the most important purpose of counselling within a PPP?

To generate a signed record for inspection regardless of patient understanding To ensure that patients and healthcare professionals understand the risk, required actions and response to failures or pregnancy To replace all clinical decisions with standardised instructions To allow educational material to contain rules different from the product information

Question 10 of 10 When identifying people to whom pregnancy-prevention conditions apply, which approach is most appropriate?

Apply the conditions solely according to chronological age Apply the conditions based on marital status and reported sexual activity Use the applicable product-specific and regulatory framework while considering relevant clinical circumstances Apply the conditions to every patient regardless of treatment context

QPPV.com

Knowledge Assessment: Pregnancy Prevention Programmes in the EU

Cookie Settings